The Glycobiology Market is being driven by Growing prevalence of cancer
The Glycobiology Market is expected to grow at a CAGR of 18.52% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2219.9 million. In the field of glycobiology, the analysis of glycosylated biomolecules requires sophisticated analytical methodologies to uncover functionally significant structural attributes. Mass Spectrometry (MS), with its diverse ionization techniques, such as Electrospray Ionization (ESI) and Matrix-Assisted Laser Desorption/Ionization (MALDI), and detection strategies, has emerged as the indispensable analytical tool in glycomics and glycoproteomics research. Furthermore, MS, coupled with its various ionization methods, mass analyzers, and detection strategies, serves as the primary approach in this domain. Complementary techniques, including microscale separation methods like Capillary Electrophoresis (CE) and Capillary Chromatography (CC), as well as carbohydrate microchemistry, have also gained significant importance in glycobiological investigations. The recent advances in glycobiological techniques have substantially expanded our understanding of glycosylation's role in health and disease.
Get more information on Glycobiology Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
174 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 18.52% |
Market growth 2024-2028 |
USD 2219.9 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
15.18 |
Key countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Glycobiology, the study of carbohydrates and their roles in living organisms, is a rapidly growing field with significant implications for various industries, particularly pharmaceutical and biotechnology. Glycomics research efforts have led to valuable learnings from proteomics examinations, revealing the importance of glycans in protein function and cellular communication. Pharmaceutical and biotechnology firms, administration groups, and academic institutions are increasing their analysis spending on glycobiology, driven by the potential for new drug discoveries and therapeutic applications. Technologies such as Capillary Electrophoresis (CE), Mass Spectrometry (MS), and High-Performance Liquid Chromatography (HPLC) are essential tools in this field, enabling the analysis of glycosides, glycosidase inhibitors, polysaccharides, lectin inhibitors, anti-glycan antibodies, glycan antigens, glycan-binding proteins, and glycans themselves. Key players in the glycobiology market include Agilent Technologies, which offers glycan analysis solutions using CE and MS technologies. The market is expected to grow significantly due to the increasing demand for glycobiology-related products and services in various industries. As the field continues to evolve, the potential applications of glycobiology in drug discovery, diagnostics, and biotechnology are vast and promising.
The global life science tools and services market is a significant segment of the larger life science industry, encompassing companies and offerings related to research and development (R&D) of various product categories. These include capital equipment, instruments, accessories, and consumables utilized in the production of pharmaceuticals, biotechnology products, and laboratory diagnostics. Additionally, the market covers life sciences-related services such as contract research, manufacturing, and sales. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. Key growth drivers for the life science tools and services market include the increasing global population aging, resulting in a larger demographic requiring healthcare solutions, and the continuous advancements in technology leading to the development of more sophisticated tools and services. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted